Peroxisome proliferator-activated receptor delta expression and regulation in mouse uterus during embryo implantation and decidualization

Molecular Reproduction and Development

Volumn 66, Issue 3, 2003, Pages 218-224

  Ding, Nai Zheng ^a   Teng, Chun Bo ^a   Ma, Hong ^a   Ni, Hua ^a   Ma, Xing Hong ^a   Xu, Li Bin ^a   Yang, Zeng Ming ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

Author keywords

Implantation; Mouse; PPAR ; Pregnancy; Uterus

Indexed keywords

ESTROGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLASTOCYST; CONTROLLED STUDY; DECIDUALIZATION; DELAYED IMPLANTATION; FEMALE; FIRST TRIMESTER PREGNANCY; HORMONAL THERAPY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MOUSE; NIDATION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOPREGNANCY; REGULATORY MECHANISM; STROMA; UTERUS;

ANIMALS; DECIDUA; EMBRYO IMPLANTATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IN SITU HYBRIDIZATION; MALE; MICE; PREGNANCY; PSEUDOPREGNANCY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TRANSCRIPTION FACTORS; UTERUS;

EID: 0141816520     PISSN: 1040452X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrd.10348     Document Type: Article

References (23)

1. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM. 1999. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4:585-595.
2. Barak Y, Liao D, He W, Ong ES, Nelson MC, Olefsky JM, Boland R, Evans RM. 2002. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci USA 99:303-308.
3. Chakraborty I, Das SK, Wang J, Dey SK. 1996. Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids. J Mol Endocrinol 16:107-122.
4. Desvergne B, Wahli W. 1999. Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocr Rev 20:649-688.
5. Guan Y, Breyer MD. 2001. Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease. Kidney Int 60: 14-30.
6. Gupta RA, Tan J, Krause WF, Geraci MW, Willson TM, Dey SK, DuBois RN. 2000. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer. Proc Natl Acad Sci USA 97:13275-13280.
7. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H, Gonzalez FJ. 1995. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15:3012-3022.
8. Lim H, Dey SK. 1997. Prostaglandin E2 receptor subtype EP2 gene expression in the mouse uterus coincides with differentiation of the luminal epithelium for implantation. Endocrinology 138: 4599-4606.
9. Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM, Dey SK. 1997. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 91:197-208.
10. Lim H, Gupta RA, Ma WG, Paria BC, Moller DE, Morrow JD, DuBois RN, Trzaskos JM, Dey SK. 1999. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPAR delta. Genes Dev 13:1561-1574.
11. Mano H, Kimura C, Fujisawa Y, Kameda T, Watanabe-Mano M, Kaneko H, Kaneda T, Hakeda Y, Kumegawa M. 2000. Cloning and function of rabbit peroxisome proliferator-activated receptor delta/beta in mature osteoclasts. J Biol Chem 275:8126-8132.
12. Matsuura H, Adachi H, Smart RC, Xu X, Arata J, Jetten AM. 1999. Correlation between expression of peroxisome proliferator-activated receptor beta and squamous differentiation in epidermal and tracheobronchial epithelial cells. Mol Cell Endocrinol 147:85-92.
13. Muoio DM, MacLean PS, Lang DB, Li S, Houmard JA, Way JM, Winegar DA, Corton JC, Dohm GL, Kraus WE. 2002. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. J Biol Chem 277:26089-26097.
14. Murohara T, Horowitz J, Silver M, Tsurumi Y, Chen D, Sullivan A, Isner J. 1998. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97:99-107.
15. Ni H, Sun T, Ding NZ, Ma XH, Yang ZM. 2002. Differential expression of microsomal PGE synthase at the implantation sites and in the decidual cells in mouse uterus. Biol Reprod 67:351-358.
16. Psychoyos A. 1986. Uterine receptivity for implantation. Ann NY Acad Sci 476:36-42.
17. Reese J, Brown N, Paria BC, Morrow J, Dey SK. 1999. COX-2 compensation in the uterus of COX-1 deficient mice during the preimplantation period. Mol Cell Endocrinol 150:23-31.
18. Schoonjans K, Staels B, Auwerx J. 1996. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1302:93-109.
19. Shi Y, Hon M, Evans RM. 2002. The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling. Proc Natl Acad Sci USA 99:2613-2618.
20. Stewart CL, Raspar P, Brunet LJ, Bhatt H, Gadi I, Kongten F, Abbondanzo SJ. 1992. Blastocyst implantation depends on maternal expression of leukemia inhibitory factor. Nature 359:76-79.
21. Wheeler-Jones C, Abu-Ghazaleh R, Cospedal R, Houliston RA, Martin J, Zachary I. 1997. Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase. FEBS Letts 420:28-32.
22. Yang ZM, Chen DB, Le SP, Yasukawa K, Harper MJK. 1996. Differential hormonal regulation of leukemia inhibitory factor (LIF) in rabbit and mouse uterus. Mol Reprod Dev 43:470-476.
23. Yoshinaga K, Adams CE. 1966. Delayed implantation in the spayed progesterone treated adult mouse. J Reprod Fertil 12:593-595.